Humacyte Inc (HUMA)

EBITDA Margin

-3734.51%

TTM · Period ending:

HUMA logo

HUMA EBITDA Margin

Latest reported-3734.51%
HUMA TTM EBITDA Margin (-3772.57% → -3734.51%)
High-resolution chart · PNG

HUMA ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Humacyte Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-3,734.512%
-3,956.6964%
-1,091.1678%
-215.2404%
-507.8051%
-774.3577%
-1,829.4687%
-246,483.871%
-1,080.4805%
156.23%
2,780.6544%
2,138.5246%
-935.8688%
-1,099.6041%
-6,075.2066%
-3,204.5141%
-4,218.7636%
-3,772.5689%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.